| 23.15 -0.36 (-1.53%) | 02-27 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
MultiPlan Corporation, through its various subsidiaries, supplies advanced data analytics and technology-driven solutions to the United States healthcare sector. These services are primarily aimed at optimizing cost management, streamlining payment processes, and ensuring the accuracy of revenue. The company leverages sophisticated algorithms and data-informed insights to deliver analytics-based services that effectively reduce medical expenses. This is achieved by detecting inflated charges on claims and either negotiating or recommending fair reimbursement amounts. Furthermore, MultiPlan offers network-focused services, which involve securing discounted rates with healthcare providers and managing the outsourced development and administration of provider networks. Its payment and revenue integrity solutions are vital for pinpointing and eliminating improper or unnecessary charges paid during the claims procedure. These services also extend to identifying and aiding in the recovery and retention of underpaid premium funds. The firm's data and decision science division provides a complete suite of solutions that employ modern data science techniques. These produce descriptive, predictive, and prescriptive analytics designed to refine benefit plan designs, facilitate strategic decision-making, enhance clinical outcomes, and lower the overall cost of care. MultiPlan also manages business-to-business healthcare payments and offers other related services. A diverse clientele benefits from MultiPlan's offerings, including major national and regional insurance carriers, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, Third-Party Administrators (TPAs), self-insured health plans, property and casualty insurers, bill review entities, and other organizations participating in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
Fri, 04 Sep 2026
MultiPlan Corporation Class A (MPLN) Peer Comparison – Compare with Others - valueresearchonline.com
Wed, 05 Mar 2025
New York health-tech company Claritev moves headquarters to Northern Virginia - The Business Journals
Wed, 26 Feb 2025
MultiPlan Corp (MPLN) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... - Yahoo Finance
Tue, 28 Jan 2025
MultiPlan Corporation's (NYSE:MPLN) top owners are private equity firms with 41% stake, while 27% is held by institutions - Yahoo Finance
Mon, 27 Jan 2025
MultiPlan Secures Massive 99% Participation in $4.5B Debt Exchange Restructuring - Stock Titan
Mon, 13 Jan 2025
MultiPlan Selects Oracle Cloud Infrastructure to Power its Business Transformation - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |